Two Sigma Securities, LLC Global Blood Therapeutics, Inc. Transaction History

Two Sigma Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $115,311 - $242,652	3,559 New	3,559 $242,000
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $295,982 - $386,510	-7,601 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $286,177 - $484,715	7,601 New	7,601 $329,000
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $238,554 - $498,609	-5,718 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $261,312 - $468,075	5,718 New	5,718 $455,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.